2000 - 2009

2009

  1. Wardah Y & SH Gan (2009). High prevalence of CYP2A6*4 and CYP2A6*9 alleles among Malaysian population. Clinica Chimica Acta (403), 105-109. (ISI-indexed, IMPACT FACTOR 2.96).
  2. SH Gan, Ramli N & Mukiar N (2009). Dual effects of low & high dose caffeine. Latin American J Pharmacy 28(3), 465-9. (ISI-indexed, IMPACT FACTOR 0.308).
  3. Navaratnam VRamanathan SWahab MSSH Gan, Mansor SMKiechel JRVaillant MTaylor WROlliaro P. (2009). Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers.Eur J Clin Pharmacol., 65(8), 809-21. (ISI-indexed, IMPACT FACTOR 2.5).
  4. Hern-Tze Tan, Rosliza A Rahman, SH Gan, AS Halim, Siti Asma’ Hassan, Siti Amrah Sulaiman, Kirnpal-Kaur B. S. (2009)“Antibacterial properties of Malaysian Tualang honey against wound and enteric microorganisms: Comparison with Manuka honey“. BMC Complementary & Alt. Med., 9, 34-42. (ISI-indexed, IMPACT FACTOR 2.01).
  5. Wardah Y & SH Gan (2009). Simultaneous detection of CYP2C8*2, CYP2C8*3, CYP2C8*4 & CYP2C8*5 alleles by a nested PCR. Asia Pacific Journal of Molecular Biology & Biotechnology, 17(2), 39-45.

2008

  1. Wan Raihana WA, SH Gan, S.C. Tan (2008). Development of a simultaneous liquid-liquid extraction and chiral derivatization method for stereospecific analysis of amphetamine-type stimulants in human urine using fractional factorial design. Biomedical Chromatography Journal 22, 1035-1042. (ISI-indexed, IMPACT FACTOR 1.61).
  2. Chua YA, Nurhaslina H & SH Gan (2008). Hyperthermic effects of Durio Zibethinusand Its Interaction with Paracetamol. Methods Exp Findings, 30(10), 739-743. (ISI-indexed, IMPACT FACTOR 1.00).
  3. Wan Raihana WA, Tan SC & Gan SH (2008). A rapid method for stereoselective analysis of amphetamine-type stimulants using simultaneous liquid-liquid extraction and chiral derivatization. Drug Metabolism Reviews 40 (S1), 41-42. (ISI-indexed, IMPACT FACTOR 6.24).
  4. Ruzilawati Abu Bakar, M Suhaimi & Gan SH (2008). Effects of CYP3A4*18 on repaglinide’s pharmacokinetics. Drug Metabolism Reviews 40 (S1), 139. (ISI-indexed, IMPACT FACTOR 6.24).
  5. Wardah Y & SH Gan (2008). Detection of CYP2A6 variant alleles commonly found in Asian populations by a duplex nested PCR. Drug Metabolism Reviews 40 (S1), 141. (ISI-indexed, IMPACT FACTOR 6.24).

2007

  1. Abu Bakar Ruzilawati, Mohd Suhaimi Abd. Wahab, Ahmad Imran, Zabidah Ismail & Gan SH (2007). Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 43, 1831-1835. (ISI-indexed, IMPACT FACTOR 2.76).
  2. Gan SH,Ismail R, Jelliffe RW, Wan Adnan WA & Zulmi W. (2007). Impact of CYP2D6 genetic polymorphism on tramadol's pharmacokinetics & pharmacodynamics. Molecular Diagnosis & Therapy, 11(3) 171-181. (ISI-indexed, IMPACT FACTOR 1.39).
  3. Abu Bakar Ruzilawati, Mohd Suhaimi Abd. Wahab, & Gan SH (2007). Genetic polymorphisms of CYP3A4CYP3A4*18allele is found in five healthy Malaysian subjects. Clin. Chimica Acta, 383, 158-162. (ISI-indexed, IMPACT FACTOR 2.96).
  4. Shimaa ABS, Sulaiman SA, A. Wahab MS, Gan SH, Ismail Z, Lope Pihie AH, Ismail R, Lam CK & Yuen KH (2007). Pharmacokinetic Interaction between propranolol & Eurycoma longlifolia extract. Malaysian Journal of Medical Sciences14 (S1), 105.

2006

  1. Gan S. H., Ismail, R., RW Jelliffe, Wan Adnan, W. A. & Zulmi, W. (2006). Population pharmacokinetics modeling of tramadol with application of the NPEM algorithms.Malaysian Journal of Medical Sciences 13 (2), 117.
  2.  Ruzilawati Abu Bakar, Gan SH & Zabidah Ismail. (2006) Method development & validation of an HPLC method for repaglinide in human plasma. Malaysian Journal of Medical Sciences 13 (2), 117.

2004

  1. Gan S. H., Ismail, R., Wan Adnan, W.A., Zulmi, W., Kumaraswamy, N. & Larmie, E. T. (2004). Relationship between Type A and B personality and debrisoquine hydroxylation capacity.Br. J. Clin. Pharmacol. 329, 61-68. (ISI-indexed, IMPACT FACTOR 2.68).
  2. Gan S. H., Ismail, R., Wan Adnan, W.A., Zulmi, W., Jelliffe, R. W. (2004). Population Pharmacokinetic Modelling of tramadol with application of the NPEM algorithms.J. Clin. Pharm. Therap. 29, 455-63. (ISI-indexed, IMPACT FACTOR 1.36).
  3.  Gan S. H., Ismail, R., Wan Adnan, W. A. & Zulmi, W. (2004). Clinical relevance of CYP2D6 genetic polymorphism on the pharmacokinetics of tramadol.Malaysian Journal of Medical Sciences 11 (1), 112-113.

2003

  1. Gan S. H., Ismail, R., Wan Adnan, W.A. & Zulmi, W. (2003). Standard CYP2D6 genotyping procedures fail for theCYP2D6*5 and duplication alleles when hair roots are used as a source of DNA. Clin. Chimica Acta. 329, 61-68. (ISI-indexed, IMPACT FACTOR 2.96).

2002

  1. Gan, S. H., Ismail, R., Wan Adnan, W. A. & Zulmi, W. (2002). Method development and validation of high-performance liquid chromatography method for tramadol in human plasma using liquid-liquid extraction. J. Chromatogr. B. 772(1), 123-129. (ISI-indexed, IMPACT FACTOR 2.971).
  2. Gan S. H., Ismail, R., Wan Adnan, W.A. & Zulmi, W. (2002). Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects. J. Pharm. Biomed. Appl. 30(2), 189-195. (ISI-indexed, IMPACT FACTOR 2.76).

2001

  1. Gan, S. H.& Ismail, R. (2001). Validation of a high-performance liquid chromatography method for tramadol and O-desmethyltramadol in human plasma using solid-phase extraction. J. Chromatogr. B. 759, 325-335. (ISI-indexed, IMPACT FACTOR 2.971).
  2. Gan S. H.& Ismail, R. (2001). High-performance liquid chromatographic determination of tramadol hydrochloride and O-desmethyltramadol in human plasma. Asia Pacific J. Pharmacol.15 (Suppl. 1).
  3. Gan S. H., Ismail, R., Wan Adnan, W. A. & Zulmi, W. (2001). Can the Visual Analogue Scale (VAS) be used to measure postoperative pain? Asia Pacific J. Pharmacol.15 (Suppl. 1).
  4. L.K. Teh, Ismail, R., Gan S. H., Rohana, Y & Abdul Rashid, A. R. (2001). Genetic polymorphism of CYP2D6 among Malays in Malaysia. Asia Pacific J. Pharmacol.15 (Suppl. 1).
  5. Gan S. H., Ismail, R., Wan Adnan, W. A. & Zulmi, W. (2001). Relationship between personality and debrisoquine hydroxylation capacity.Malaysian Journal of Medical Sciences 8 (2), 71-72.

2000

  1. Gan S. H.& Ismail, R. Postoperative pain management: Is it adequate? A preliminary study. 3rd National Symposium on Health Sciences, Universiti Kebangsaan Malaysia (2000); 409-412.. (2006) Method development & validation of an HPLC method for repaglinide in human plasma. Malaysian Journal of Medical Sciences 13 (2), 117.

 

© 2017 GanSiewHua.com All Rights Reserved.

Search